Nucleic Acid Based Gene Therapy Market Research and Clinical Analysis 2020 - Wave Life Sciences, Imugene, Caperna, Phylogic
The global nucleic acid based gene therapy market was worth $557.47 million in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 10.00% and reach $816.18 million by 2023.
Prob loads of these around viralytics used to be in them all the time but good to research if seriously invested to know what’s being distributed around major funds in us etc
Read more: http://m.digitaljournal.com/pr/4846135#ixzz6bRaafbKW
IMU: investment pros and cons, page-42
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $378.4M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.1¢ | $482.5K | 9.199M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 2314617 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1506472 | 14 |
View Market Depth
| Last trade - 12.24pm 31/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |